Trial site
University of California, Irvine Health
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Epilepsy1 trial
- Kidney cancer1 trial
- Neurofibromatosis type 11 trial
- Pancreatic cancer1 trial
- Peripheral artery disease1 trial
- Pompe disease1 trial
- and 1 more
- Phase
- Phase 24 trials
- Phase 1/23 trials
- Phase 33 trials
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Actuate Therapeutics Inc.1 trial
- Deciphera Pharmaceuticals, LLC1 trial
- Eisai Inc.1 trial
- Nerviano Medical Sciences1 trial
- Nuvalent Inc.1 trial
- and 6 more
Running trials
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Active, not recruiting
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Terminated
Completed
UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
Site data: ClinicalTrials.govUpdated 18 Nov 2026